drugset / Trial / NCT04809532

Trans Abdominis Plane (TAP) Block in Patients With Cesarean Section

NCT04809532

Unknown 60 enrolled Armed Forces Hospital, Pakistan
RandomizedParallel-groupOpen-labelPrevention

Summary

Objective: To compare Trans Abdominis Plane block in providing post cesarean analgesia with control group, in terms of mean postoperative use of Opioids. Study design: Randomized controlled trial. Place and duration Department of Anesthesiology, Combined Military Hospital, Sargodha, 25th February 2021 to 25th April 2021. Materials and methods: A total of 60 female patients, who are planned to undergo elective c section and aged between 20-45 will be selected randomly and divided into two groups ( A and B) with 30pts each group. In Group A, at the end of surgery, TAP block will be given with 20ml of 0.25%bupvicaine via ultrasound guided sub-costal approach on both sides of midline. Time of TAP block will be recorded as time 0. Our outcomes will be: mean postoperative consumption of opioids and VAS score within 24hrs of surgery. Independent t test will be used to compare group A and B in terms of mean usage of tramadol within 24hrs of surgery. P value \<0.05 will be considered statistically significant.

Timeline

Start
2021-02-25
Primary completion
2021-04-25
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 20 ml Other
Background Tramadol Other / unclassified Intravenous

Indications

No indication recorded.